Ad Header



The Pulse of the Pharmaceutical Industry

W2O Group’s Sentient Adds Dominic Viola and Michael Spitz To Leadership Team

Written by: | | Dated: Wednesday, August 16th, 2017


W2O Group’s Sentient Adds Dominic Viola and Michael Spitz To Leadership Team as Digital MarCom Firm Scales Fully-Integrated Offering to Over 150 People

Dominic Viola

Michael Spitz


San Francisco and Morristown, N.J., August 16, 2017— W2O Sentient, a digital marketing and communications firm grounded in analytics and insights, announced today the appointment  of respected industry leaders Dominic Viola as Managing Director, Client Services, and Michael Spitz as Practice Leader, Strategy.

Viola brings 20 years of healthcare experience and joins from FCBCURE, where he served as EVP, Group Management Director. He will be based in the Morristown office.  Spitz, an industry veteran with diverse career experience, joins the company from Klick Health, where he served as VP of Strategy. Previously, he was SVP of Digital Health at Edelman. He will be based in the New York office.

Since joining forces with W2O Group about eight months ago, we have experienced tremendous growth and strengthened our leadership team to support it with industry veterans, including Dom and Mike, both of whom I’ve had the pleasure of working with over the past decade,” said Adam Cossman, President of Sentient and W2O Group’s Chief Digital Officer. “Sentient is naturally evolving from a purely digital firm into a full-service integrated marketing and communications firm that can do much more than ever for our clients.”

Sentient, by expanding its portfolio of services to include strategy, analytics, advertising, and social and paid media, is creating a fully-integrated marketing and communications offering born from its digital heritage and integrating its and W2O’s proprietary analytics at all phases. It now boasts more than 150 full-time people dedicated to providing its own and other W2O Group operating company clients with an end-to-end solution set to address their most challenging and opportunistic business situations.

“Sentient has been awarded several major full-service, agency of record assignments this year spanning advertising, digital, paid media and social programs,” added Jim Weiss, Founder and CEO of W2O Group. “These wins are supported and fueled by the W2O model, which is rooted in analytics-driven insights that inform marketing and communications strategy and programming.”  


About Sentient

Since 2008, Sentient has provided services to clients in diverse industries, including life sciences, financial services and consumer packaged goods. Sentient is now a part of the W2O Group, an independent, global network of marketing, analytics and communications firms delivering innovative integrated business solutions for the world’s leading companies and brands. For more information on Sentient, please visit


About W2O Group

Founded and led by CEO Jim Weiss in 2001, W2O Group is an independent, fast-growing network of complementary digital marketing and communications firms focused on integrated business solutions to drive change and growth for the world’s leading brands and organizations. W2O Group firms employ proprietary analytics models, methodologies and approaches that uncover key insights leading to precise communications and marketing strategies and engagement to deliver business results. W2O Group’s network includes WCGTwist MktgPure, Marketeching and Sentient, with a growing footprint of offices in the United States and Europe. For more information, please visit


Follow W2O Group on Twitter
Follow W2O Group on LinkedIn
Follow W2O Group on Facebook


# #  #


CONFIDENTIALITY NOTICE: This e-mail, along with any documents, files, or attachments, may contain information that is confidential, privileged, or otherwise exempt from disclosure. If you are not the intended recipient or person responsible for delivering it to the intended recipient, you are hereby notified that any disclosure, copying, printing, distribution or use of any information contained in or attached to this e-mail is strictly prohibited. If you have received this e-mail in error, please immediately notify the sender and delete the original e-mail and its attachments without reading, printing, or saving in any manner. This e-mail message should not be interpreted to include a digital or electronic signature that can be used to authenticate an agreement, contract or other legal document, nor to reflect an intention to be bound to any legally-binding agreement or contract. Your cooperation is appreciated. Thank you.

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom